ArticleFrontiers in medicine2025
Clinical features and laboratory indicators of dengue infection in China: a retrospective study of adult patients in a hospital of traditional Chinese medicine.
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Position Statement on the Management of Antithrombotic and Anticoagulant Therapy in Dengue - 2026.Arquivos brasileiros de cardiologia · 2026Article
- Monocyte TLR2/4 as predictive biomarkers for progression from dengue warning signs to severe disease.Frontiers in immunology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Dengue is an arboviral disease caused by the dengue virus, primarily transmitted by mosquitoes in tropical and subtropical regions. Despite preventive measures, the incidence and mortality of dengue remain significant. While the acute phase of infection often presents with mild, self-limiting symptoms and may mimic other undifferentiated febrile illnesses, the risk of mortality is particularly high during the acute phase of secondary infections, which are associated with more severe clinical manifestations. Liver dysfunction has been strongly linked to the severity of the disease, and it plays a critical role in determining patient outcomes. Methods: This retrospective observational study was conducted at Foshan Hospital of Traditional Chinese Medicine, including 533 hospitalized dengue patients diagnosed between June and December 2024. Clinical symptoms (e.g., fatigue, headache, muscle pain, dry mouth, rash, nausea) and laboratory parameters (e.g., complete blood count, liver function tests, lactate dehydrogenase, C-reactive protein, procalcitonin) were collected. Patients were categorized into three groups based on liver function test results: non-liver injury (ALT ≤ 40 U/L, AST ≤ 40 U/L), mild liver injury (ALT or AST levels between 40 U/L and 80 U/L), and severe liver injury (ALT > 80 U/L or AST > 80 U/L). Results: Among the 533 patients, 48.03% were male and 51.97% were female, with the majority (61.35%) in the 51-80 years age range. Common clinical symptoms included fatigue (92.50%), poor appetite (90.99%), dry mouth (62.66%), and headache (52.53%). Significant laboratory abnormalities included leukopenia (63.41%), thrombocytopenia (80.11%), and elevated liver enzymes (AST 84.99%, ALT 52.53%). Stratification based on liver injury severity showed that the severe liver injury group had significantly higher levels of inflammatory markers (CRP, PCT), and tissue damage markers (LDH, CK) compared to the non-liver injury and mild liver injury groups. The severe liver injury group also had a younger median age compared to the other two groups ( Conclusion: Dengue patients commonly present with symptoms such as fatigue, poor appetite, and dry mouth, with laboratory abnormalities including leukopenia, thrombocytopenia, and elevated liver enzymes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.